Company Quick10K Filing
Diego Pellicer
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 50 $1
10-Q 2019-11-18 Quarter: 2019-09-30
10-Q 2019-08-19 Quarter: 2019-06-30
10-Q 2019-05-15 Quarter: 2019-03-31
10-K 2019-04-16 Annual: 2018-12-31
10-Q 2018-11-14 Quarter: 2018-09-30
10-Q 2018-08-20 Quarter: 2018-06-30
10-Q 2018-05-15 Quarter: 2018-03-31
10-K 2018-04-17 Annual: 2017-12-31
10-Q 2017-11-20 Quarter: 2017-09-30
10-Q 2017-08-29 Quarter: 2017-06-30
10-Q 2017-06-26 Quarter: 2017-03-31
10-K 2017-05-03 Annual: 2016-12-31
10-Q 2016-11-14 Quarter: 2016-09-30
10-Q 2016-08-15 Quarter: 2016-06-30
10-Q 2016-05-20 Quarter: 2016-03-31
10-K 2016-04-29 Annual: 2015-12-31
10-Q 2015-11-16 Quarter: 2015-09-30
10-Q 2015-08-14 Quarter: 2015-06-30
10-Q 2015-05-19 Quarter: 2015-03-31
10-K 2015-01-28 Annual: 2014-12-31
10-Q 2014-11-13 Quarter: 2014-09-30
10-Q 2014-08-12 Quarter: 2014-06-30
10-Q 2014-05-27 Quarter: 2014-03-31
10-K 2014-05-15 Annual: 2013-12-31
8-K 2020-02-18 Regulation FD, Exhibits
8-K 2019-10-29
8-K 2019-09-25
8-K 2019-09-10
8-K 2019-08-08
8-K 2019-07-23
8-K 2019-07-10
8-K 2019-06-24
8-K 2019-04-09
8-K 2019-02-19
8-K 2019-02-14
8-K 2019-01-30
8-K 2019-01-15
8-K 2018-12-19 Regulation FD, Exhibits
8-K 2018-12-19 Regulation FD, Exhibits
8-K 2018-12-10 Regulation FD, Exhibits
8-K 2018-12-05 Regulation FD, Exhibits
8-K 2018-10-31
8-K 2018-10-31
8-K 2018-10-03
8-K 2018-09-07
8-K 2018-08-23
8-K 2018-08-13
8-K 2018-08-06
8-K 2018-07-31
8-K 2018-07-24
8-K 2018-07-19
8-K 2018-07-19
8-K 2018-07-17
8-K 2018-06-20
8-K 2018-01-18

Diego Pellicer Financials

DPWW Metrics, Comps, Filings

Annual | Quarterly

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Argos Therapeutics (ARGS) 1,165 0% -1.3 -106% 10,881 23,454 8,905 0 -11,529 -8,973 11,710
West Coast Ventures (WCVC) 1,135 0% -0.3 -88% 2,746 6,463 3,402 0 -2,427 -3,366 847
Yulong Eco-Materials (YECO) 1,133 31% 0.0 -200% 33,278 29,559 10,084 3,137 -66,490 -64,932 -681
Acacia Diversified Holdings (ACCA) 1,090 32% -0.8 -176% 830 1,652 615 199 -1,457 -1,303 1,029
Capstone Therapeutics (CAPS) 1,088 -0% -1.7 -261% 703 3,463 -4,000 0 -1,834 -1,736 2,961
Oncolix (ONCX) 1,085 -1.0 -2,427% 297 7,602 0 0 -7,200 -6,988 7,169
Q2Earth (QPWR) 1,040 1% -2.8 -153% 201 4,661 2,896 33 -307 -307 859
HST Global (HSTC) 1,034 -5.1 0 965 0 0 -178 -205 1,034
ColorStars (CSTU) 1,023 100% -3.8 -221% 120 426 9 9 -265 -262 1,008
Arias Intel (ASNT) 1,014 -0.1 -1,260% 723 6,449 0 0 -9,111 -8,536 1,014
Diego Pellicer (DPWW) 1,009 3,773% -0.2 -202% 4,958 13,966 14 509 -10,023 -6,806 1,350
Altex Industries (ALTX) 986 0% -117.7 0% 2,394 1,084 54 0 3 11 -1,294
Tearlab (TEAR) 976 83% -11.6 -20% 15,939 39,071 17,686 14,716 -3,220 -2,282 26,567
TX Holdings (TXHG) 961 16% 10.0 0% 2,309 4,224 3,898 627 9 147 1,462
Axion Power (AXPW) 960 -2,624% -0.1 -1,826% 578 8,143 58 -1,527 -10,558 -10,312 759
Lone Star Gold (LSTG) 901 -1% -21.1 -20% 212 313 107 -1 -42 -42 885
ZIM (ZIMCF) 895 -0% 0 0 0 0 388
Blue Sphere (BLSP) 894 34% -0.6 -33% 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Network CN (NWCN) 877 -18.2 -802% 112 12,320 0 0 -896 -323 5,869
GTx (GTXO) 869 84% -2.2 -92% 1,028 4,224 1,234 1,032 -945 -877 1,907

Balance Sheet ($'000)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash11425365115960
Accounts Receivable010171149
Inventory8147330
PP&E22839758409140
Assets117271,4141,7031,1131,018
Accounts Payable626613
Long-Term Debt
Liabilities155813,0025,3087,0579,062
Stockholders' Equity-39-54-1,588-3,606-5,944-8,044
Income Statement ($'000)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue9852305374
Cost of Revenue18168
Gross Profit8036366275327
R&D
SG&A7714,2685,021-5,8002,853
Tax000000
Net Income25-20-16,518-7,067-14,650-6,684
Cash Flow ($'000)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating79-82-2,653-557-1,041-1,202
Cash Investing-20-785-857-1250
Cash Financing19-23,4411,4301,2731,103